Diagnostic Strategy for Females Suspected of Fabry Disease

18. Februar 2020

Fabry disease, an X-linked inherited lysosomal storage disorder, can be overlooked in heterozygous females due to random X-inactivation. In...

Read more

Hemoglobinopathies and β-Thalassemia: Investigating High-Res Mass Spectrometry

18. Februar 2020

Early diagnosis of hemoglobin disorders and Thalassemias are become more important due to a high carrier frequency and ease...

Read more

amedes and ARCHIMEDlife – a new strong international alliance in providing health care services

17. Januar 2020

ARCHIMEDlife is very proud to announce the strategic alliance with amedes Holding GmbH, a leading provider in interdisciplinary and...

Read more

New cut-offs for lysosomal enzyme activities.

6. Juni 2019

We are happy to inform you that we have introduced a new diagnostic assay for the analysis of lysosomal...

Read more

TDM für Psychopharmaka: (in German)

26. Februar 2019

Quantitative Bestimmung von Psychopharmaka in Blut, Serum oder Plasma Modernste Analysetechnik mittels Klinischer Massenspektrometrie (exakt, sensitiv, schnell) Kompetente fachärztliche Auskunft...

Read more

First LEA assay launched

14. März 2018

LEA2 MPS Panel Our first LEA2 (Lysosomal Enzyme Activity) assay has now been started and with it several mucopolysaccharidoses...

Read more

Awarded work starting into a prospective study: Hemoglobinopathies and Thalassemias

14. März 2018

Our awarded work (Poster Finalist at MSACL Europe, also see the PDF Poster Hemoglobinopathies_MSACL) on hemoglobinopathies and thalassemias is now...

Read more

Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine (Lyso-Gb3) and time to initiation of enzyme replacement therapy, an observational study

7. März 2018

Introduction: Methods: Results:  Conclusion: Authors / corresponding author*  JAlbinaNowakaSarah H.HailebDavid C.KaspercThomas P.MechtlercAndreas J.FlammeraPierre A.KrayenbuehldDaniel P.Franzena   University Hospital Zurich,...

Read more

Novel diagnostics for Rare Disorders: Fabry in females, presented at WorldSymposium

7. März 2018

The parallel measurement of lyso-GL-3 (lyso-Gb3) for Fabry disease is of high importance particularly for potential female Fabry patients,...

Read more

5 years ARCHIMEDlife – Thanks to our partners, clients and friends!

21. November 2017

The 21st of November 2017  is ARCHIMEDlife´s 5th anniversary, a proof that out of an idea you can evolve...

Read more